2009-11-10 17:39:04 -
Trinity Biotech Plc - Medical Equipment - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/trinity-biot ..
Trinity Biotech Plc (Trinity Biotech) is engaged in the development and manufacture of diagnostic systems, reagents and instrumentation for the point of care and clinical laboratory markets. The products are used by medical laboratory technologists and bio-chemists to detect infectious diseases and blood coagulation disorders, to quantify the level of Haemoglobin A1c and for other chemistry parameters in serum, plasma
and whole blood. The company principally operates in Ireland, the US, Germany, France, the UK and Sweden. It is headquartered at Co Wicklow, Ireland. In March 2009, the company commenced CLIA trials for its TRIstat point-of-care HbA1c product.
The Trinity Biotech Plc - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
